myeloma x and xi trials: outcomes for multiple myeloma patients
Published 8 years ago • 139 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
3:38
outcomes for patients with multiple myeloma who have had first-line monoclonal antibody exposure
-
1:59
outcomes from myeloma xi - what do the results tell us?
-
0:59
defining the origins of multiple myeloma
-
3:12
updated results of the linker-mm1 trial: linvoseltamab in r/r multiple myeloma
-
3:50
evolution of autosct in multiple myeloma: patient demographics and improved outcomes
-
1:40
barriers that remain in finding a cure for multiple myeloma
-
10:42
ep 40 - multiple myeloma update jan 2022 - revlimid - zometa side effects - dental work
-
4:04
the future of myeloma treatment and the possibility of cure
-
2:38
how close is a cure for multiple myeloma?
-
2:02
alnuctamab, a bcma x cd3 tce, in the treatment of multiple myeloma
-
2:30
a new era of treatment for multiple myeloma
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:57
the safety and efficacy of iberdomide for the treatment of multiple myeloma
-
1:22
an all-molecular diagnostic approach for myeloma
-
2:44
myeloma qol through induction and maintenance
-
1:29
insights into the biology of high-risk myeloma and advances being made in this space
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
1:41
innovative treatment strategies for multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
2:07
advancements in clinical trials for high-risk newly diagnosed multiple myeloma